Trial · NCT04187144
Results by group472
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 472
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S (IA Set) | Gepotidacin | Therapeutic Success | 162 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S (IA Set) | Nitrofurantoin | Therapeutic Success | 115 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S (IA Set) | Gepotidacin | Therapeutic Failure | 115 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S (IA Set) | Nitrofurantoin | Therapeutic Failure | 149 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S Population | Gepotidacin | Therapeutic Success | 172 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Therapeutic Success | 121 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S Population | Gepotidacin | Therapeutic Failure | 120 | Participants | |
| Number of Participants With Therapeutic Response (TR) (Combined Per Participant Clinical and Microbiological Response) at the Test-of-Cure (TOC) Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Therapeutic Failure | 154 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Clinical Resolution | 199 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Clinical Resolution | 175 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Clinical Improvement (CI) | 51 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Clinical Improvement (CI) | 68 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Clinical Worsening (CW) | 20 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Clinical Worsening (CW) | 17 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Unable to Determine | 22 | Participants | |
| Number of Participants With Clinical Outcome at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Unable to Determine | 15 | Participants | |
| Number of Participants With Clinical Response at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Clinical Success | 199 | Participants | |
| Number of Participants With Clinical Response at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Clinical Success | 175 | Participants | |
| Number of Participants With Clinical Response at the TOC Visit - Micro-ITT NTF-S Population | Gepotidacin | Clinical Failure | 93 | Participants | |
| Number of Participants With Clinical Response at the TOC Visit - Micro-ITT NTF-S Population | Nitrofurantoin | Clinical Failure | 100 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04187144/results